PE20011034A1 - Pirroles sustituidos como agentes antiproliferativos - Google Patents
Pirroles sustituidos como agentes antiproliferativosInfo
- Publication number
- PE20011034A1 PE20011034A1 PE2000001346A PE0013462000A PE20011034A1 PE 20011034 A1 PE20011034 A1 PE 20011034A1 PE 2000001346 A PE2000001346 A PE 2000001346A PE 0013462000 A PE0013462000 A PE 0013462000A PE 20011034 A1 PE20011034 A1 PE 20011034A1
- Authority
- PE
- Peru
- Prior art keywords
- indol
- alkyl
- methyl
- substituted
- nr6r7
- Prior art date
Links
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical group C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 title 1
- 230000001028 anti-proliverative effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 abstract 2
- -1 2-METHOXY-ETHOXY Chemical class 0.000 abstract 1
- KOLMZGIDCNVGEI-UHFFFAOYSA-N 3-[(diethylazaniumyl)methyl]benzoate Chemical compound CCN(CC)CC1=CC=CC(C(O)=O)=C1 KOLMZGIDCNVGEI-UHFFFAOYSA-N 0.000 abstract 1
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 101100295741 Gallus gallus COR4 gene Proteins 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 1
- 230000022131 cell cycle Effects 0.000 abstract 1
- 230000032823 cell division Effects 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
SE REFIERE A PIRROLES SUSTITUIDOS DE FORMULA I, DONDE R ES -PO3R1R2, CHR3OCOR4, CHR3OCO2R4, CHR3OCONHR4, COR4; R1 Y R2 SON H, Na, NH4 O JUNTOS SON Ca; R3 ES H, METILO; R4 ES ALQUILO (SUSTITUIDO CON CO2R5, NR6R7, POLIETEILENGLICOL, -OPO3R1R2, OH, ALCOXILO, ARILO), ALQUENILO, CICLOALQUILO, HETEROCICLO, ARILO; R5 ES H, Na, ALQUILO; R6 Y R7 SON H, ALQUILO, CO2R8 O NR6R7 FORMA UN HETEROCICLO DE 5-6 MIEMBROS; R8 ES ALQUILO SUSTITUIDO POR POLIETILENGLICOL CON PESO MOLECULAR DE 750 DALTONS A 5000 DALTONS. SON COMPUESTOS PREFERIDOS ESTER 3-[4-(1-METIL-6-NITRO-1H-INDOL-3-IL)-2,5-DIOXO-2,5-DIHIDRO-1H-PIRROL-3-IL]-INDOL-1-ILMETILICO DEL ACIDO 3-[2-(2-METOXI-ETOXI)-ETOXI]-PROPIONICO; CLORHIDRATO DE ESTER 3-[4-(1-METIL-6-NITRO-1H-INDOL-3-IL)-2,5-DIOXO-2,5-DIHIDRO-1H-PIRROL-3-IL]-INDOL-1-ILMETILICO DEL ACIDO 3-DIETILAMINOMETIL-BENZOICO, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. LOS COMPUESTOS INHIBEN LA DIVISION CELULAR EN FASE G2/M DEL CICLO CELULAR Y PUEDE SER UTIL PARA EL TRATAMIENTO DE TRASTORNOS PROLIFERATIVOS COMO CANCER DE MAMA, COLON, PULMON
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17105199P | 1999-12-16 | 1999-12-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20011034A1 true PE20011034A1 (es) | 2001-10-12 |
Family
ID=22622296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2000001346A PE20011034A1 (es) | 1999-12-16 | 2000-12-14 | Pirroles sustituidos como agentes antiproliferativos |
Country Status (33)
Country | Link |
---|---|
US (1) | US6313143B1 (es) |
EP (1) | EP1242408B1 (es) |
JP (2) | JP2003516986A (es) |
KR (1) | KR100507422B1 (es) |
CN (1) | CN1229374C (es) |
AR (1) | AR029415A1 (es) |
AT (1) | ATE306484T1 (es) |
AU (1) | AU783616B2 (es) |
BR (1) | BRPI0016329B8 (es) |
CA (1) | CA2392902C (es) |
CO (1) | CO5050293A1 (es) |
CZ (1) | CZ304130B6 (es) |
DE (1) | DE60023182T2 (es) |
ES (1) | ES2249314T3 (es) |
GC (1) | GC0000265A (es) |
HK (1) | HK1054385B (es) |
HR (1) | HRP20020513B1 (es) |
HU (1) | HU230003B1 (es) |
IL (2) | IL150128A0 (es) |
JO (1) | JO2296B1 (es) |
MA (1) | MA26856A1 (es) |
MX (1) | MXPA02005560A (es) |
MY (1) | MY126998A (es) |
NO (1) | NO322240B1 (es) |
NZ (1) | NZ519173A (es) |
PE (1) | PE20011034A1 (es) |
PL (1) | PL200243B1 (es) |
RS (1) | RS50449B (es) |
RU (1) | RU2264398C2 (es) |
TW (1) | TWI274752B (es) |
UY (1) | UY26485A1 (es) |
WO (1) | WO2001044234A1 (es) |
ZA (1) | ZA200204258B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002102373A1 (en) * | 2001-06-15 | 2002-12-27 | F. Hoffmann-La Roche Ag | Method for administration of cancer therapeutic |
EP1441772A2 (en) * | 2001-10-29 | 2004-08-04 | Nektar Therapeutics Al, Corporation | Polymer conjugates of protein kinase c inhibitors |
US9107911B2 (en) | 2010-01-07 | 2015-08-18 | Alkermes Pharma Ireland Limited | Prodrugs of heteraromatic compounds |
EP2474541A1 (en) * | 2010-12-23 | 2012-07-11 | Johannes- Gutenberg-Universität Mainz | Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ227850A (en) | 1988-02-10 | 1991-11-26 | Hoffmann La Roche | Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders |
GB9416467D0 (en) * | 1994-08-13 | 1994-10-05 | Wellcome Found | Compounds for use in medicine |
CN1304058C (zh) * | 1996-03-12 | 2007-03-14 | Pg-Txl有限公司 | 水溶性紫杉醇产品 |
TW517067B (en) * | 1996-05-31 | 2003-01-11 | Hoffmann La Roche | Interferon conjugates |
PE91498A1 (es) * | 1996-07-29 | 1998-12-22 | Hoffmann La Roche | Pirroles sustituidos |
PE91598A1 (es) | 1996-07-29 | 1998-12-24 | Hoffmann La Roche | Pirroles sustituidos |
PE91698A1 (es) | 1996-07-29 | 1998-12-24 | Hoffmann La Roche | Pirroles sustituidos |
JP2002500184A (ja) * | 1998-01-09 | 2002-01-08 | アリゾナ ボード オブ リーゼンツ | フェンスタチンとそのプロドラッグの合成 |
TR200002580T2 (tr) * | 1998-03-17 | 2000-11-21 | F.Hoffmann-La Roche Ag | Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler |
US6350786B1 (en) * | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
JP2003511449A (ja) * | 1999-10-12 | 2003-03-25 | エフ.ホフマン−ラ ロシュ アーゲー | 癌の処理のための抗増殖剤としての置換されたピロール |
-
2000
- 2000-11-07 US US09/707,678 patent/US6313143B1/en not_active Expired - Lifetime
- 2000-12-11 JO JO2000198A patent/JO2296B1/en active
- 2000-12-12 DE DE60023182T patent/DE60023182T2/de not_active Expired - Lifetime
- 2000-12-12 EP EP00983288A patent/EP1242408B1/en not_active Expired - Lifetime
- 2000-12-12 WO PCT/EP2000/012559 patent/WO2001044234A1/en active IP Right Grant
- 2000-12-12 AT AT00983288T patent/ATE306484T1/de active
- 2000-12-12 JP JP2001544724A patent/JP2003516986A/ja not_active Withdrawn
- 2000-12-12 RU RU2002119209/04A patent/RU2264398C2/ru active
- 2000-12-12 KR KR10-2002-7007517A patent/KR100507422B1/ko active IP Right Grant
- 2000-12-12 RS YUP-433/02A patent/RS50449B/sr unknown
- 2000-12-12 MX MXPA02005560A patent/MXPA02005560A/es active IP Right Grant
- 2000-12-12 CN CNB008170665A patent/CN1229374C/zh not_active Expired - Lifetime
- 2000-12-12 CA CA002392902A patent/CA2392902C/en not_active Expired - Lifetime
- 2000-12-12 HU HU0203696A patent/HU230003B1/hu unknown
- 2000-12-12 NZ NZ519173A patent/NZ519173A/en not_active IP Right Cessation
- 2000-12-12 PL PL355856A patent/PL200243B1/pl unknown
- 2000-12-12 ES ES00983288T patent/ES2249314T3/es not_active Expired - Lifetime
- 2000-12-12 AU AU20082/01A patent/AU783616B2/en not_active Expired
- 2000-12-12 CZ CZ20022447A patent/CZ304130B6/cs not_active IP Right Cessation
- 2000-12-12 BR BRPI0016329A patent/BRPI0016329B8/pt not_active IP Right Cessation
- 2000-12-12 IL IL15012800A patent/IL150128A0/xx active IP Right Grant
- 2000-12-13 CO CO00094815A patent/CO5050293A1/es unknown
- 2000-12-14 AR ARP000106636A patent/AR029415A1/es active IP Right Grant
- 2000-12-14 PE PE2000001346A patent/PE20011034A1/es not_active IP Right Cessation
- 2000-12-14 MY MYPI20005871A patent/MY126998A/en unknown
- 2000-12-15 UY UY26485A patent/UY26485A1/es not_active Application Discontinuation
- 2000-12-16 GC GCP20001101 patent/GC0000265A/en active
- 2000-12-16 TW TW089126995A patent/TWI274752B/zh not_active IP Right Cessation
-
2002
- 2002-05-28 ZA ZA200204258A patent/ZA200204258B/en unknown
- 2002-06-10 IL IL150128A patent/IL150128A/en unknown
- 2002-06-11 NO NO20022776A patent/NO322240B1/no not_active IP Right Cessation
- 2002-06-12 HR HR20020513A patent/HRP20020513B1/xx not_active IP Right Cessation
- 2002-06-14 MA MA26691A patent/MA26856A1/fr unknown
-
2003
- 2003-09-16 HK HK03106629.3A patent/HK1054385B/zh not_active IP Right Cessation
-
2007
- 2007-01-22 JP JP2007011821A patent/JP4763623B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20210154A1 (es) | Derivados de piridincarbonilo y usos terapeuticos de los mismos como inhibidores de trpc6 | |
AU2016229136A1 (en) | DNA alkylating agents | |
PE20121010A1 (es) | Derivados de bencimidazol | |
BG106440A (en) | Nitrogen-heterocyclic derivatives as nos inhibitors | |
JP2016128456A5 (es) | ||
BRPI0417267A (pt) | derivados de triazol como antagonistas de vasopressina | |
AR048642A1 (es) | Compuestos de metil-aril o heteroaril-amida sustituida utiles como antagonistas del receptor de prostaglandinas e2; composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento | |
TW200734337A (en) | Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists | |
DE60042762D1 (de) | Zwischenprodukte für die Herstellung von Harnstoffderivaten mit Muskarinrezeptor-antagonistischer Aktivität | |
AR049647A1 (es) | Cis-imidazolinas | |
UY26086A1 (es) | Procedimientos e intermedios para preparar compuestos anticancerosos | |
PT1065204E (pt) | Compostos de carbonil-indole biciclicos como agentes anti-inflamatorios/analgesicos e como inibidores de cox-2 | |
BRPI0601311A (pt) | mercaptosilanos | |
ES2191260T3 (es) | Derivados de la imidazolidin-4-ona utiles como agentes anticancerosos. | |
RU2013109132A (ru) | Химические соединения | |
ATE144772T1 (de) | Piperazinderivate | |
PE20011034A1 (es) | Pirroles sustituidos como agentes antiproliferativos | |
PE20000340A1 (es) | Pirroles sustituidos | |
ES2165430T3 (es) | Analogos fluorados del 2-nitroimidazol para detectar celulas tumorales hipoxicas. | |
Harrowven et al. | CH activation and CH 2 double activation of indolines by radical translocation: Understanding the chemistry of the indolinyl radical | |
ES2311847T3 (es) | Nuevos derivados de imidazoles, su prepracion y su utilizacion como medicamento. | |
WO2016092556A1 (en) | 7-(morpholinyl)-2-(n-piperazinyl) methyl thieno [2, 3-c] pyridine derivatives as anticancer drugs | |
Houlihan et al. | Structural modification of 5-aryl-2, 3-dihydroimidazo [2, 1-a] isoquinoline platelet activating factor receptor antagonists | |
PE20010695A1 (es) | Pirroles sustituidos como agentes antiproliferativos | |
MA19604A1 (fr) | Procede de preparation de nouvelles triazoloquinazolones et leurs sels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal | ||
FG | Grant, registration | ||
MK | Expiration of term |